BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20696223)

  • 1. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate.
    Kojima T; Tsutsumi S; Yamamoto K; Ikeda Y; Moriwaki T
    Int J Pharm; 2010 Oct; 399(1-2):52-9. PubMed ID: 20696223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy.
    Allesø M; Velaga S; Alhalaweh A; Cornett C; Rasmussen MA; van den Berg F; de Diego HL; Rantanen J
    Anal Chem; 2008 Oct; 80(20):7755-64. PubMed ID: 18798651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction crystallization of pharmaceutical molecular complexes.
    Rodríguez-Hornedo N; Nehm SJ; Seefeldt KF; Pagan-Torres Y; Falkiewicz CJ
    Mol Pharm; 2006; 3(3):362-7. PubMed ID: 16749868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
    Karki S; Friscić T; Jones W; Motherwell WD
    Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cocrystallization tendency: the role of intermolecular interactions.
    He G; Jacob C; Guo L; Chow PS; Tan RB
    J Phys Chem B; 2008 Aug; 112(32):9890-5. PubMed ID: 18646803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
    Ervasti T; Aaltonen J; Ketolainen J
    Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hansen solubility parameter as a tool to predict cocrystal formation.
    Mohammad MA; Alhalaweh A; Velaga SP
    Int J Pharm; 2011 Apr; 407(1-2):63-71. PubMed ID: 21256944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocrystallization via planetary milling: enhancing throughput of solid-state screening methods.
    Bysouth SR; Bis JA; Igo D
    Int J Pharm; 2011 Jun; 411(1-2):169-71. PubMed ID: 21439363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical cocrystals: an overview.
    Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
    Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph.
    Limwikrant W; Nagai A; Hagiwara Y; Higashi K; Yamamoto K; Moribe K
    Int J Pharm; 2012 Jul; 431(1-2):237-40. PubMed ID: 22537807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
    Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
    Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast dissolving eutectic compositions of curcumin.
    Goud NR; Suresh K; Sanphui P; Nangia A
    Int J Pharm; 2012 Dec; 439(1-2):63-72. PubMed ID: 23041131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.
    Manin AN; Voronin AP; Drozd KV; Manin NG; Bauer-Brandl A; Perlovich GL
    Eur J Pharm Sci; 2014 Dec; 65():56-64. PubMed ID: 25218047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals.
    Yamamoto K; Tsutsumi S; Ikeda Y
    Int J Pharm; 2012 Nov; 437(1-2):162-71. PubMed ID: 22871562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.